Ozempic-maker Novo Nordisk on Friday ousted its CEO Lars Fruergaard Jorgensen over concerns the company is losing its ...

If you’ve been on TikTok or any other social media — or any kind of media, for that matter — you’ve probably come across ...

Jorgensen became CEO in January 2017 and the company’s market capitalization has more than tripled during his tenure. Novo was first to market with Wegovy and its sister drug Ozempic for diabetes, but ...

In a recent episode of The Joe Rogan Experience on Thursday, Harvard historian Rebecca Lemov discussed an experiment conducted by Facebook in 2012. What Happened: A 2012 Facebook experiment that ...

Lars Fruergaard Jorgensen, the chief executive of once-highflying Danish drugmaker Novo Nordisk, is stepping down after eight years in the role, the maker of Ozempic and Wegovy drugs announced on ...

Reuters, the news and media division of Thomson Reuters, is the world’s largest multimedia news provider, reaching billions ...

Ozempic and Mounjaro, originally diabetes medications, have exploded in popularity as powerful weight-loss injectables.

A smaller, streamlined cabinet helped Mark Carney signal change. But his new cabinet is bigger, counting helpers, than ...

Mounjaro. Ozempic. Wegovy. Zepbound. All these are brand names linked in some way to diabetes and weight loss-or, as the ...

President Trump shared a story about a businessman friend's frustration with the high cost of a weight-loss drug in the U.S.

Donald Trump appeared to admit being on Ozempic as he laid out his new executive order's plan to lower prescription drug ...

Advocates say P.E.I.’s early implementation of pharmacare was the result of pre-existing government programs aimed at ...